|
End-of-day quote
Other stock markets
|
||
| - GHS | - |
|
| Market Cap | 5.2M 60.71M 4.52M 4.2M 3.86M 7.29M 496M 7.4M 49.56M 19.45M 247M 19.52M 19.09M 828M | P/E 2017 |
11.7x | P/E 2018 | 6.9x |
|---|---|---|---|---|---|
| Enterprise Value | 10.45M 122M 9.08M 8.45M 7.76M 14.65M 997M 14.88M 99.63M 39.1M 496M 39.23M 38.37M 1.66B | EV / Sales 2017 |
1.34x | EV / Sales 2018 | 1.05x |
| Free-Float |
26.89% | Yield 2017 * |
-
| Yield 2018 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | 0.00% | - | - | 915K | ||
| -2.79% | -6.82% | +45.11% | +148.43% | 1,024B | ||
| -1.22% | -4.99% | +47.73% | +48.08% | 618B | ||
| -2.06% | -4.33% | +24.65% | +64.91% | 443B | ||
| +0.68% | -1.14% | +39.61% | +33.36% | 349B | ||
| -1.66% | -3.13% | +31.63% | +39.79% | 297B | ||
| -8.96% | -10.77% | +3.27% | +5.50% | 264B | ||
| -1.37% | -7.41% | -3.42% | -43.67% | 209B | ||
| -1.70% | +0.81% | +25.62% | +64.41% | 208B | ||
| -0.35% | -0.48% | +13.44% | +71.98% | 162B | ||
| Average | -2.09% | -1.35% | +25.29% | +48.09% | 357.38B | |
| Weighted average by Cap. | -2.09% | -2.17% | +32.88% | +70.34% |
| 2017 | 2018 | |
|---|---|---|
| Net sales | 8.89M 104M 7.73M 7.2M 6.61M 12.48M 849M 12.67M 84.81M 33.29M 423M 33.4M 32.66M 1.42B | 9.91M 116M 8.61M 8.02M 7.36M 13.9M 946M 14.12M 94.51M 37.09M 471M 37.22M 36.4M 1.58B |
| Net income | 665K 7.77M 578K 538K 494K 933K 63.48M 947K 6.34M 2.49M 31.61M 2.5M 2.44M 106M | 762K 8.9M 662K 616K 566K 1.07M 72.7M 1.08M 7.26M 2.85M 36.19M 2.86M 2.8M 121M |
| Net Debt | 4.15M 48.45M 3.61M 3.36M 3.08M 5.82M 396M 5.91M 39.55M 15.52M 197M 15.57M 15.23M 661M | 5.25M 61.33M 4.56M 4.25M 3.9M 7.36M 501M 7.48M 50.07M 19.65M 249M 19.72M 19.28M 837M |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- SPL Stock
Select your edition
All financial news and data tailored to specific country editions
















